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Abstract  57 
Background: Several malnutrition screening tools have been advocated for use in pediatric 58 
inpatients.  59 
Objective: This study evaluated how three popular pediatric nutrition screening tools 60 
(Pediatric Yorkhill Malnutrition Score-PYMS, Screening Tool for the Assessment of 61 
Malnutrition in Pediatrics-STAMP and Screening Tool for Risk of Impaired Nutritional 62 
Status and Growth-STRONGKIDS) compare and relate to anthropometry, body composition 63 
and clinical parameters in patients admitted to tertiary hospitals across Europe. 64 
Design: The three screening tools were applied in 2567 inpatients in 14 hospitals in 12 65 
European countries. Classification of patients into different nutritional risk groups was 66 
compared between tools and related to anthropometry and clinical parameters (e.g. length of 67 
stay, LOS; infection rates).  68 
Results: A similar rate of completion of the screening tools for each tool was achieved 69 
(PYMS 86%, STAMP 84%, STRONGKIDS 81%). Risk classification differed markedly 70 
among tools, with an overall agreement of 41% between the tools. Children categorized at 71 
high risk (PYMS 25%, STAMP 23% and STRONGKIDS 10%) had a longer LOS compared to 72 
children at low risk (1.4, 1.4 and 1.8 days longer, respectively, p<0.001). Among high-risk 73 
patients identified with PYMS, 22% had a low (<-2 SD) body mass index (BMI) and 8% a 74 
low height-for-age (HFA). For STAMP the respective percentages were 19% and 14% and 75 
for STRONGKIDS 23% and 19%.  76 
Conclusion: Identification and classification of malnutrition risk varies among the pediatric 77 
tools used. A considerable portion of children with subnormal anthropometry was not 78 
identified with all tools. The data obtained do not allow recommending using any of these 79 
screening tools for clinical practice.  80 
  81 
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Introduction  85 
Malnutrition screening has been advocated as part of patients’ standard care (1-3). This is 86 
because malnutrition upon admission or deterioration of the nutritional status during 87 
hospitalisation has been associated with prolonged hospital stay and adverse outcomes (e.g. 88 
increased rates of complications such as infections) although causality in these associations 89 
remains to be explored (4-7). Early identification of nutritional risk followed by an 90 
appropriate nutritional management was proposed as part of routine clinical practice (8). The 91 
“Guidelines for nutrition screening” by the European Society for Clinical Nutrition and 92 
Metabolism (ESPEN) provide recommendations for adult patients but do not address pediatric 93 
patients (9). Screening tools for assessing malnutrition risk for adults have been available for 94 
many years (9-11). However similar pediatric tools have only recently been developed and 95 
were only tested in small cohorts of hospitalized children (5, 7, 12-14). These tools consist of 96 
questions related to the patient’s history and measurements or clinical estimation of body size 97 
to assess the risk of poor nutritional status (15). They aim to screen all inpatients and identify 98 
those missed during routine admission and whose disease outcome would improve or would 99 
not deteriorate from tailored nutritional intervention. However, there is a lack of sufficient 100 
data on the predictive value of such pediatric screening tools on outcome and objective 101 
indices of malnutrition in large multicentre studies, and of comparative evaluation of the 102 
various tools. Addressing these aspects may direct health professionals on their decision to 103 
select the most suitable nutritional screening tool.  104 
We compared the risk scoring of three previously proposed pediatric nutrition screening 105 
tools, i.e. the Pediatric Yorkhill Malnutrition Score (PYMS) (16, 17), the Screening Tool for 106 
the Assessment of Malnutrition in Pediatrics (STAMP) (13) and the Screening Tool for Risk 107 
Of Impaired Nutritional Status and Growth (STRONGKIDS) (5) in a large multi-centre study in 108 
children admitted to hospitals across Europe. In addition we explored the agreement among 109 
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the tools (concurrent validity) and the relation of risk scores to anthropometry and body 110 
composition measurements as well as clinical parameters, such as hospital length of stay 111 
(LOS). 112 
It is arguable which could be the best outcome measure for the assessment of the effect of 113 
using a screening tool as it is somewhat controversial as to whether such screening tools 114 
should predict anthropometry or clinical outcome. Therefore, in this study we aimed to 115 
explore the association of the scores provided by the tools with both subnormal BMI and with 116 
length of hospital stay (LOS).  117 
 118 
Subjects and methods 119 
Study design and subjects 120 
This prospective European multi-centre cohort study enrolled patients from February 121 
2010 to July 2011 in 14 centres in 12 countries (Zagreb, Croatia; Copenhagen; Denmark, 122 
Lille, France; Munich, Germany; Thessaloniki, Greece, Petah Tikvah, Israel; Milan, Italy; 123 
Rotterdam and Groningen, the Netherlands; Warsaw, Poland; Cluj-Napoca, Romania; Oxford, 124 
England and Glasgow, Scotland). Patients (1 month to 18 years old) admitted to pediatric and 125 
pediatric surgery wards with an anticipated length of stay >24 hours were eligible to 126 
participate. They were consecutively invited to participate whenever data collection was 127 
possible within the first 24 hours after admission. Patients attending the accident and 128 
emergency department of the day care unit were excluded. 129 
We excluded children admitted to intensive care because of the limited feasibility to 130 
perform detailed anthropometry on the day of admission in critically ill children. To identify 131 
children at risk of malnutrition in this group of patients is redundant, since all of these 132 
children are -by the nature of their critical illness (e.g. unconscious hence unable to eat)- at 133 
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high risk of malnutrition and therefore should receive respective attention of the medical and 134 
dietetic staff. The principle of screening is to identify those at risk who might go missed, and 135 
to refer to the clinical team. We also excluded children admitted to day hospital care because 136 
their expected LOS was shorter than 24 hours. Patients with cerebral palsy or genetic 137 
syndromes were not excluded per protocol. Details about the recruitment and the protocol 138 
have been previously published by Hecht el al (18). 139 
 140 
Methods 141 
Patients were assessed by a set of questions considering nutritional risk, and 142 
measurements of anthropometry and body composition were all performed within the first 24 143 
hours after admission. The assessors were a multidisciplinary team including research nurses, 144 
dietitians, medical students and nutritionists. A training workshop to harmonise recruitment 145 
and standardise anthropometry and data collection among the different centres was held in 146 
March 2010 at Munich, Germany.  147 
Demographic and medical data together with a questionnaire for nutritional status were 148 
collected during a structured interview with patients and (when required) their caregivers. The 149 
questionnaire integrated the 4 items of the PYMS tool (16, 17), the 3 items of the STAMP 150 
tool (13) and the 4 items of the STRONGKIDS screening tool (5) and sorted them by item 151 
content. For each patient, the steps of each tool were completed by the same investigator in 152 
the same order. The total score for each screening tool was computed during the analysis of 153 
the data. The 28 assessors were encouraged not to add the scores for each tool during data 154 
collection to avoid bias by the knowledge on categorization in a screening tool. Only the 155 
treating physicians and dietitians, and not the assessors, decided on whether or not to start 156 
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nutritional support during hospitalisation. This decision was taken according to normal 157 
routine procedures and was not by any means influenced by the study data.  158 
Important characteristics of PYMS (1, 16, 17), STAMP (13, 19), and STRONGKIDS (5, 159 
19) are reported in Supplemental Table 1. PYMS and STAMP include anthropometry (BMI 160 
vs. weight and height, respectively); STRONGKIDS includes a subjective clinical assessment 161 
of nutritional status. Total scores for each tool were computed for those age groups for which 162 
the tools were validated: PYMS was completed for patients aged 1 to 16 years, STAMP for 163 
patients aged 2 to 16 years and STRONGKIDS for patients aged 1 month to 18 years. For the 164 
comparison of the three tools, only children aged 2-16 years were considered, since patients 165 
within this age range account as eligible for screening by all three tools.  166 
Data on height, weight, mid upper arm circumference (MUAC) and triceps skin fold 167 
thickness (TSFT) were collected. Methods have been described previously by Hecht el al (18). 168 
Clinical parameters, including LOS as primary outcome and frequency of infectious 169 
complications (number of days with temperature >38.5° C and number of days with antibiotic 170 
use) were derived from hospital records after discharge.  171 
The total score and classification of malnutrition risk (low, medium or high) was 172 
determined for each study participant and screening tool. The scores obtained by the three 173 
screening tools were then related to anthropometry, body composition and outcome data. For 174 
the cross-tabulation of risk classification between the tools we decided to group the 175 
classification of malnutrition risk into two rather than three categories (i.e. “high”: vs. 176 
“medium+low”) as children allocated in the high group category are the ones that need to be 177 
further referred for assessment to the dietetic and clinical team. 178 
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The study protocol was accepted by the local research/medical ethic committees of each 179 
participating centre. Prior to participation informed written consent was obtained by parents 180 
and their caregivers (whenever required).  181 
 182 
Statistical analysis 183 
Risk scores were cross-tabulated within the three screening tools, and agreement rates 184 
were computed (concurrent validity). The Cohen’s kappa statistic test was applied to describe 185 
the level of agreement between the two tools (20) taking into account the agreement occurring 186 
by chance. Baseline characteristics between groups were compared using Fisher’s exact test 187 
or Pearson’s chi2-test for categorical data. Linear regression analysis was applied separately 188 
for gender to adjust the association of risk for malnutrition with TSFT and MUAC for age, 189 
chronic disease and centre. Residuals were checked for normal distribution. In clinical 190 
practice a substantial intervention (e.g. referral to a dietitian) will only occur in children with 191 
a high-risk score. Therefore in all data analysis except for the random coefficient model, low 192 
and medium risk patients for each screening tool were combined and presented as one group 193 
versus the high-risk patients.  194 
Age- and gender-specific BMI and WFH SD-scores were calculated using the WHO 195 
reference data: WHO growth reference study data were used for children aged 1 month to ≤5 196 
years (http://www.who.int/childgrowth/software/en/) and further age-adequate WHO 197 
reference data were used for patients aged >5-18 years (http://www.who.int/growthref/en/). 198 
MUAC and TSFT SD-scores based on WHO reference data were limited to patients aged 3 199 
months to 5 years.  200 
Multilevel mixed-effects Poisson regression was used to accommodate the general 201 
dependence of LOS on the centre of the patient and the existing differences in severity and 202 
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type of chronic diseases between centres. Thus, centre was included as a random effect while 203 
additionally allowing varying effects by chronic disease status. The association of each 204 
nutritional risk classification by PYMS, STAMP and STRONGKIDS with LOS was tested 205 
including age, sex and chronic disease status as confounders. An interaction between chronic 206 
disease status and nutritional risk classification was also tested.  207 
Furthermore, the percentages of children with suboptimal skinfolds or MUAC and 208 
suboptimal BMI who were correctly identified or misclassified at high risk of malnutrition by 209 
each tool were calculated and compared to each other. Also the percentage of children 210 
classified at high risk despite a normal MUAC, TSFT or BMI was compared among the three 211 
tools. In order to have the same children included for each tool, only children aged 2-5 years 212 
were included for the analysis of SD-scores for MUAC and TSFT. 213 
Data management and statistical analyses were carried out with R 2.13.2 (The R 214 
Foundation for Statistical Computing; Vienna, Austria) and Stata 12.1 (StataCorp LP, 215 
College Station, TX). 216 
 217 
Results 218 
Patient characteristics 219 
A total of 2567 patients (median age 4.7 years; IQR: 1.4, 11.1 years) were enrolled into 220 
the study (80% general and 20% pediatric/surgical patients). Nearly half of the study 221 
population were females (44.9%), 44.8% had an underlying chronic disease and were 222 
electively admitted (18). Most study participants were of Caucasian origin (91%) and were at 223 
home prior to admission (91%). Nutritional support prior to admission was administered to 224 
11.8% of the study population. During the hospital stay nutritional support was given to 225 
12.3% of the participants (6.2% oral supplements, 6.1% tube feeding and 0.8% parenteral 226 
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nutrition, with few overlaps), of whom 76% were already receiving it prior to their admission. 227 
Some 20% of children who received nutritional support prior to admission were not allocated 228 
to a nutritional support regime after admission, according to hospital data. 229 
Median length of hospital stay was 4 days (IQR: 3, 7 days). A BMI <-2 SDS was present 230 
in 7.0% of the study population at hospital admission, whereas for HFA<-2 SDS this was the 231 
case for 7.9% of the participants. 232 
 233 
Completion of the screening tools 234 
As each of the three screening tools were developed for different age ranges, the number 235 
of eligible children these could be applied to varied among them. Some 933 patients were 236 
either <2 or ≥16 years and therefore STAMP could not be completed. Similarly, for 621 237 
participants aged either <1 or ≥16 years PYMS could not be applied. In total, PYMS was 238 
completed for 1664 (86% of the children in the targeted aged group: 1–16 years), STAMP 239 
was completed for 1374 study participants (84% of children in the targeted aged group: 2–16 240 
years), and STRONGKIDS was completed for 2089 (81% of the children in the targeted aged 241 
group: 1 month –18 years). For almost half of the study group (1258 children, 49%) all three 242 
tools have been completed. The completion rates of each individual component of the three 243 
tools are listed in Table 1. As the researchers occasionally found it challenging to respond to 244 
some of the steps of the individual tools, a numbers of screens were left incomplete.  245 
 246 
Malnutrition risk classification  247 
The classification of malnutrition risk of the assessed children by the three screening tools 248 
shows a substantial variation among the different tools (Figure 1). The risk classification 249 
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distribution varied markedly also within and between countries (Figure 2). Overall the 250 
proportion of high risk patients ranged between 5-51% (PYMS: 15-51%, STAMP: 9-51% and 251 
STRONGKIDS: 5-30%). The greatest difference between the proportions of high-risk patients 252 
based on the 3 screening tools within one centre was 32% (Greece).  253 
For the 1258 patients in whom all three tools were completed, the distribution of risk 254 
classification according to the three screening tools is shown in Supplemental Figure 1. In 255 
more detail, in this subgroup of 1258 patients the different tools categorized 10% 256 
(STRONGKIDS) to 22% (STAMP and PYMS) of children in the high-risk group. In total only 257 
87 participants (7% of all patients with three completed tools) were jointly rated as at high 258 
risk for malnutrition from all three tools. Less than half of the patients (41%) were classified 259 
at the same risk level for malnutrition with the use of the three different tools. This percentage 260 
increased to 74% when children with low and medium risk were group together and 261 
compared to the high risk group. The agreement between the tools, accounting for statistical 262 
chance, was fair to moderate. (20) 263 
 Pairwise comparison resulted in 55% agreement for PYMS with STAMP (κ=0.31, CI: 264 
0.28, 0.35) and 58% PYMS with STRONGKIDS (κ=0.33, CI: 0.29, 0.37). The greatest degree 265 
of agreement was found between STAMP and STRONGKIDS (60%, κ=0.37, CI: 0.33, 0.40). 266 
This agreement increased to 74% when a combined classification “low+medium” versus the 267 
“high” risk group was used. Pairwise comparison between tool pairs resulted in approx. 80% 268 
agreement and is shown in Table 2 (PYMS vs. STAMP: moderate agreement, PYMS vs. 269 
STRONGKIDS: fair agreement, and STAMP vs. STRONGKIDS : fair agreement) (21). 270 
 271 
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Clinical characteristics of patients in the three risk groups for each tool 272 
Characteristics of children within the risk groups of each screening tool are described in 273 
Table 3. The proportion of patients with an underlying chronic disease was higher for patients 274 
identified with high risk vs. medium or low risk for STAMP (75% vs. 53% or 36%) and 275 
STRONGKIDS (89% vs. 48% or 30%). With the use of PYMS patients with a chronic disease 276 
were equally classified into the three risk categories (48% vs. 49% or 48%). The 277 
administration of nutritional support both prior to admission or during the hospital stay was 278 
higher for patients identified with high risk vs. medium or low risk for all three tools
.
 279 
Additionally, high-risk patients identified with all three tools experienced fever more 280 
frequently and were prescribed more antibiotics than medium-risk-patients and low-risk-281 
patients. 282 
LOS increased from low to high-risk patients as identified by all three tools (Table 3). 283 
This was also supported by the effect estimates of the multivariate regression analysis taking 284 
age, sex, chronic disease and centre into account (Table 4).  285 
Risk categorization and anthropometry 286 
Mean SD-scores for either BMI or HFA were significantly different between the 3 risk 287 
groups within each tool. (Table 3 and in more details in Supplemental Table 2). 288 
Additionally, a considerable number of children with low BMI (<-2SD) were not picked up as 289 
high-risk (and were categorized either in the low or in the medium risk category) by the three 290 
tools. Table 5 displays relevant differences among the 3 tools for the group of children 291 
(n=1253) who completed all three tools and had BMI data available.  292 
MUAC and TSFT were measured in 2263 (88%) and 2094 (82%) study participants 293 
respectively. Linear regression results for all three screening tools showed a significant 294 
relationship between malnutrition risk and MUAC for both sexes after adjustment for age, 295 
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chronic disease and centre. SD-scores for MUAC and TSFT for patients ≥ 2 years and ≤ 5 296 
years of age in relation to the risk groups of each screening tool can be found in Table 6.  297 
 298 
Discussion 299 
The aim of all three screening tools is to identify children at risk of malnutrition on 300 
admission to select patients for further evaluation and potential intervention. However, there 301 
are differences concerning the use of these tools, as they were designed for application by 302 
different users (pediatricians, nurses etc.) and in different age groups (5, 13, 17). Additionally, 303 
PYMS and STAMP include anthropometry, while STRONGKIDS focuses on identifying 304 
children at nutritional risk on admission by visual inspection of body habitus alone.  305 
This study found marked differences in the number of patients who could be screened by 306 
the three tools. Also the scores and classification of malnutrition risk among children varied 307 
substantially according to the tool used. Few smaller studies conducted previously have 308 
looked into the agreement in nutritional risk classification using PYMS, STAMP and 309 
STRONGKIDS, and also found this to be modest (19, 22-24). Lack of agreement may be 310 
explained by the fact that the tools are different, albeit containing similar steps. While several 311 
components within the tools are similar, there are discrepancies in scoring, duration of recall 312 
history and approaches to assess body size.  313 
By definition (item 1) PYMS was expected to categorize all children with a BMI <-2SD 314 
into the high risk category. However, this was not the case for a low number of children (7 315 
out of 96) with suboptimal BMI not identified correctly by PYMS. This is likely to be 316 
explained by discrepancies in the values of low BMI threshold (<2nd centile), between the 317 
WHO growth charts, we used to analyse the data, and the UK-WHO adapted version cited on 318 
the original PYMS form. 319 
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 In this study, we assessed the discriminant validity of the screening outcomes of each 320 
tool against body composition and explored their ability to predict adverse clinical outcomes. 321 
For each tool we found a reverse association between malnutrition risk with body 322 
composition and a positive one with LOS. In particular, children scored at high risk for 323 
malnutrition, for each tool, stayed longer in the hospital and had lower mean MUAC and 324 
TSFT values than the patients with low or medium risk. It should be emphasized that 325 
sensitivity and cut off points of MUAC are still debatable, and MUAC might be a more 326 
valuable tool in assessing markedly malnourished children. However, it is often considered 327 
useful in the clinical assessment and follow-up of patients.  328 
The association between the risk score classification and LOS was strongest with 329 
STRONGKIDS. It is, however, unclear how much of this association is explained by disease 330 
severity and how much is attributed to the effect of malnutrition. 331 
It is arguable which would be the best benchmark assessing the value of a screening tool. 332 
Amaral et al (3) and Kyle et al (25) found a significant association between the screening 333 
score of nutrition risk screening tools and LOS in adults, but they stated that LOS is also 334 
influenced by many non-nutritional factors. However, adverse effects of malnutrition and the 335 
influence of the underlying disease interact and both affect LOS, which should be considered 336 
when assessing associations of risk scores and secondary outcomes such as fever or use of 337 
antibiotics.  338 
We think that it is important that the tools would agree in the detection of the high risk 339 
patients including those with a subnormal BMI, HFA and skinfold thickness measurements, 340 
which was not the case in this study. We consider as high-risk patients those who need to be 341 
referred to a more detailed assessment and are more likely to need nutritional intervention. 342 
Moreover, screening tools are also aiming to identify children at risk of deterioration of 343 
malnutrition risk due to an acute medical insult despite normal anthropometry at hospital 344 
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admission. This encompasses a large proportion of children admitted in acute settings in 345 
developed countries and intervention and prevention of weight loss is probably as important 346 
as correction of weight loss and growth catch up in those children who are already 347 
malnourished (26). 348 
Strengths of our study are its multicentre setting and the large number of participants 349 
from different countries. To our best knowledge this is the first study that compares three 350 
different screening tools in a large pediatric population. We used one growth reference (the 351 
WHO growth standard) for all children and thereby excluded the variation between different 352 
country specific growth charts. However, we did not use disease specific growth charts, as 353 
available, for example, for cerebral palsy patients, because these are only available for a few 354 
selected diagnoses and have generally not been based on pan-European patient populations.. 355 
We also acknowledge that our study may have suffered from a sample selection bias as some 356 
children who were severely sick may have not joined the study. Additionally a substantial 357 
number of children were on nutritional support at study entry which most likely reflects the 358 
profile of patients who regularly attend the highly specialised hospitals which participated in 359 
this study. A further potential limitation of this study is the fact that we did not perform full 360 
nutritional assessment as a reference for the comparison of the screening scores (1, 17). 361 
Moreover, with our data we could not account for the effect of disease groups or severity on 362 
the association between malnutrition risk and clinical outcome. The power to detect nutrition-363 
associated infections is limited by the generally short LOS of the patients included in the 364 
study, which reflects current clinical practice. Large differences were found between 365 
countries, which may reflect differences in population characteristics or clinical practice. 366 
Furthermore, our study evaluated the screening tools in the specific study population enrolled, 367 
and extrapolation of results to other populations may be done cautiously.  368 
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While for all three tools significant associations were observed between high risk of 369 
malnutrition with increased LOS and suboptimal anthropometry, the agreement among tools 370 
to classify the same patients at the same risk of malnutrition was modest. While screening 371 
tools have potential in enhancing clinicians’ awareness on the importance of nutritional status 372 
of pediatric patients (1, 23), raising awareness amongst health care professionals alone is not 373 
a sufficient justification for establishing an additional investigation in patients. Rather, a 374 
reasonable prediction of the risk of malnutrition or of outcome with a good sensitivity and 375 
specificity is expected, as a prerequisite for clinical routine use of a screening tool.  376 
While STRONGKIDS is not based on anthropometric measurements, the authors 377 
describing STRONGKIDS also advocate measuring weight and height as part of assessing 378 
nutritional status on admission after the initial risk screening. PYMS or STAMP are based on 379 
anthropometry and thus detect the large majority of children with abnormal anthropometric 380 
measures (26, 27). However, the use of these tools may be at the expense of too many 381 
children being categorized as high risk. Other aspects need to be considered too, such as the 382 
clinical performance and impact of any selected tool on current health care resources (e.g. 383 
staff workload, practicality).  384 
Identification and classification of risk of malnutrition varied among tools and countries. 385 
The agreement between s tools was modest, a finding which partially might be attributed to 386 
the absence of and a consensus definition and agreed measurements of malnutrition. Based on 387 
these findings, no firm conclusions can be drawn about the superiority of one tool over the 388 
other tool. Beyond diagnostic validity, we recommend that the selection of the most 389 
appropriate tool, for routine use on hospital admission, will further depend on its clinical 390 
performance, the availability of and impact on health care resources.  391 
 392 
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Table 1: Scoring of screening tool items for the group of children aged 2-16 years (N=1724) who 
completed all tools (N = 1258) expressed as N (%) 
 
Scores of children completing 
ALL tools 
 n = 1258 (%) 
Children aged 2-16 years 
 n = 1724 (%) 
ITEMS1 0 1 2 3 
Total 
Assessed 
Not assessed 
according to 
original tool 
questions 
Item 1: Current 
nutritional condition2   
PYMS (0-2) 
1152 
(92) 
 
106 
(8) 
 
1538 
(89) 
186 (11) 
STAMP (0-1-3) 
967 
(77) 
169 
(13) 
 
122 
(10) 
1474 
(85) 
250 (15) 
STRONGKIDS (0-1) 
1031 
(82) 
227 
(18) 
  
1607 
(93) 
117 (7) 
Item 2: Weight loss3   
PYMS (0-1) 
1036 
(82) 
222 
(18) 
  
1568 
(91) 
156 (9) 
STAMP (NA)       
STRONGKIDS (0-1)  
1027 
(82) 
231 
(18) 
  
1633 
(95) 
91 (5) 
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Item 3: Reduced 
intake4 
 
 
PYMS (0-1-2) 
1004 
(80) 
228 
(18) 
26  
(2) 
 
1633 
(95) 
91 (5) 
STAMP (0-2-3) 
913 
(73) 
 
317 
(25) 
28  
(2) 
1633 
(95) 
91 (5) 
STRONGKIDS (0-1) 
861 
(68) 
397 
(32) 
  
1633 
(95) 
91 (5) 
Item 4: Underlying 
disease5 
  
PYMS (0-1-2) 
994 
(79) 
255 
(20) 
9 
(1) 
 
1509 
(88) 
215 (12) 
STAMP (0-2-3) 
670 
(53) 
 
324 
(26) 
264 
(21) 
1529 
(89) 
195 (11) 
STRONGKIDS (0-2) 
893 
(71) 
 
365 
(29) 
 
1515 
(88) 
209 (12) 
 
1
 Possible scores are put in parentheses and for each item differ for each tool 
Risk classification according to total scores differs between the tools:  
low risk:  PYMS: 0 points,  STAMP: 0-1 points,  STRONGKIDS: 0 points 
medium risk: PYMS: 1 point,  STAMP: 2-3 points,  STRONGKIDS: 1-3 points  
high risk:  PYMS: 2-7 points,  STAMP: 4-9 points,  STRONGKIDS: 4-5 points 
2Item 1:  
PYMS: Is the BMI below the cut-off value shown in the BMI Scoring Guide? 
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STAMP: Use a growth chart or the centile quick reference tables to determine the child’s weight 
and height measurements.  
STRONGKIDS: Is the patient in a poor nutritional status judged by subjective clinical assessment? 
3Item 2: 
PYMS: Has the child lost weight recently? 
STRONGKIDS: Is there weight loss or poor weight gain (infants <1 year) during the last few 
weeks/months? 
4Item 3: 
PYMS: Has the child had a reduced intake (including feeds) for at least the past week? 
STAMP: What is the child’s nutritional intake? 
STRONGKIDS: Is one of the following items present: excessive diarrhoea (≥5/day) and/ or vomiting 
(>3/day), reduced food intake during the last few days, pre-existing nutritional intervention or 
inadequate nutritional intake due to pain? 
5Item 4: 
PYMS: Will the child’s nutrition be affected by the recent admission/condition for at least the next 
week? 
STAMP: Does the child have a diagnosis that has any nutritional implication? 
STRONGKIDS: Is there an underling illness with risk for malnutrition or expected major surgery? 
 
PYMS: Pediatric Yorkhill Malnutrition Score; STAMP: Screening Tool for the Assessment of 
Malnutrition in Pediatrics; STRONGKIDS: Screening Tool for Risk Of Impaired Nutritional Status 
and Growth.  
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Table 2: Cross-tabulation of risk classification between PYMS, STAMP and STRONGKIDS 
PYMS: Pediatric Yorkhill Malnutrition Score; STAMP: Screening Tool for the Assessment of 
Malnutrition in Pediatrics; STRONGKIDS: Screening Tool for Risk Of Impaired Nutritional Status 
and Growth.  
 Risk for malnutrition   
 
 
low + medium high 
  
agreement 82% 
( n=1308) 
STAMP 
  
PYMS 
low + medium 897 121 
κ= 0.47  
(CI: 0.42, 0.53) high 118 172 
agreement 83% 
( n = 1318) 
STRONGKIDS   
STAMP
 
low + medium 990  32 
κ= 0.39  
(CI: 0.33, 0.45) high 187 109 
agreement 81% 
(n = 1490) 
PYMS
 
  
STRONGKIDS 
low + medium 1088  249 
κ= 0.35  
(CI: 0.28, 0.42) high 39 114 
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Table 3: Characteristics of children within the risk groups of each screening tool 
 
PYMS (1–16y) 
N=1664 
STAMP (2–16y) 
N=1374 
STRONGKIDS (1m–18y) 
N=2089 
 
Low 
N=943 
Medium 
N=305 
High 
N=416 
Low 
N=512 
Medium 
N=547 
High 
N=315 
Low 
N=915 
Medium 
N=968 
High 
N=206 
Median age (y) 
(95% IQR) 
7.4  
(3.6, 11.3) 
5.8  
(3.0, 11.3) 
4.4  
(2.0, 9.9) 
8.3 
(4.7, 12.0) 
7.8  
(4.1, 12.0) 
7.6  
(3.8, 12.3) 
5.1 
(1.3, 11.2) 
4.4 
(1.4, 10.6) 
6.3 
(1.9, 12.6) 
Age groups (%) 
31 days – 0.9 y 0 0 0 0 0 0 21 18 15 
1 – 1.9 y 12 13 24 0 0 0 10 14 10 
2 – 5.9 y 30 37 34 34 39 41 23 26 24 
6 – 12.9 y 40 32 29 49 41 38 29 26 27 
13 – 17.9 y 18 18 13 17 20 21 17 17 24 
Female (%) 44 50 43 46 45 43 44 45 44 
Caucasian (%) 92 93 90 94 91 92 92 91 88 
Acute admission (%) 45 54 65 52 48 53 48 62 58 
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Chronic disease (%) 48 49 48 36 53 75 30 48 89 
Surgical (%) 20 21 17 16 21 19 25 15 20 
BMI- SDS (mean, SD) 
0.52 
(1.23) 
0.28 
(1.14) 
-0.77 
(1.58) 
0.46  
(1.17) 
0.15 
(1.23) 
-0.30 
(1.85) 
0.42 
 (1.25) 
-0.04 
(1.37) 
-1.19 
(1.61) 
HFA-SDS (mean, SD) 
0.15 
(1.37) 
0.19 
(1.43) 
-0.19 
(1.54) 
0.38  
(1.25) 
0.02 
(1.29) 
-0.34 
(1.62) 
0.37  
(1.31) 
0.04  
(1.38) 
-0.86 
(1.97) 
Nutritional support (%) 
Prior admission 
6 11 24 1 9 26 1 11 54 
Nutritional support (%) 
During hospitalization 
5 12 25 1 9 27 2 11 56 
LOS (median (IQR), days) 4 (3, 6) 5 (3, 8) 5 (3, 9) 4 (3, 7) 4 (3, 7) 5 (3, 8) 4 (3, 7) 4 (3, 7) 6 (3, 10) 
Secondary outcomes (%)  
Fever (%)1 10 21 29 10 17 19 13 23 23 
Use of antibiotics (%)2 28 44 44 28 33 41 28 43 44 
 
1
 At least one event-day of fever 
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2
 At least one event-day of antibiotics 
PYMS: Pediatric Yorkhill Malnutrition Score; STAMP: Screening Tool for the Assessment of Malnutrition in Pediatrics; STRONGKIDS: Screening 
Tool for Risk Of Impaired Nutritional Status and Growth. BMI: body mass index; SDS: standard deviation score; HFA: height for age; LOS: length of 
stay. 
Percentages and median (IQR) are reported for the total number of children in the risk groups of each screening tool. 
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Table 4: Relationship between LOS and nutritional risk classification using a random 
coefficient model1 (95% CI), P-value 
 
PYMS  
(N=1669) 
STAMP 
(N=1379) 
STRONGKIDS 
(N=2089) 
Low risk - - - 
Medium risk 
1.112 
(1.05, 1.18) 
< 0.001 
1.08 
(1.02, 1.14) 
0.005 
1.19 
(1.14, 1.24) 
< 0.001 
High risk 
1.38 
(1.32, 1.45) 
< 0.001 
1.37 
(1.29, 1.46) 
< 0.001 
1.82 
(1.72, 1.93) 
< 0.001 
 
1 Adjusted for Age, sex and chronic disease status and taking the dependence within 
centres into account while 
2 Comparison to low risk category, i.e. medium risk patients stayed 1.11 days longer 
in the hospital than the low risk patients scored by PYMS. 
PYMS: Pediatric Yorkhill Malnutrition Score; STAMP: Screening Tool for the 
Assessment of Malnutrition in Pediatrics; STRONGKIDS: Screening Tool for Risk Of 
Impaired Nutritional Status and Growth; LOS: length of stay. 
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 Table 5: BMI SD-scores within the risk groups of three malnutrition risk screening tools (for the 1253 out of 1258 completing all tools) 
BMI 
PYMS (2–16y) 
 
N=12531  
STAMP (2–16y) 
 
N=12531  
STRONGKIDS (2-16y) 
 
N=12531  
Low 
N= 757 
Medium 
N=222  
High 
N= 274 
Low 
N= 485 
Medium 
N= 494 
High 
N= 274 
Low 
N=575 
Medium 
N=550 
High 
N=128 
Mean  
(SD) 
 0.50  
( 1.25) 
 0.23 
( 1.16) 
 -0.78 
( 1.55) 
 0.45  
( 1.18) 
 0.14 
( 1.23) 
 -0.27 
( 1.88) 
 0.53 
( 1.26) 
 0.05 
( 1.39) 
 -0.88 
( 1.50) 
≥ -1SDS 
 687   190   147   437 410 177  518   434 72  
<-1 to ≥-2 SDS  66  
 30   67   42  75  46  49  88  26 
< -2 SDS  4   2   60   6  9  51  8  28  30 
% of BMI <-2SD 
NOT categorized in 
the high-risk group 
9.1%  
(6/66) 
22.7% 
(15/66) 
54.6% 
(36/66)  
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1
 All children with completion of the tool and BMI.For 5 children no BMI could be calculated due to length value missing. 
PYMS: Pediatric Yorkhill Malnutrition Score; STAMP: Screening Tool for the Assessment of Malnutrition in Pediatrics; STRONGKIDS: 
Screening Tool for Risk Of Impaired Nutritional Status and Growth; SD: standard deviation; BMI: body mass index. 
 
The Am
erican Journal of Clinical Nutrition AJCN/2015/110700 Version 4
 34
Table 6: MUAC and TSFT SD-scores for children ≥2 and ≤5 years old within the risk groups of three 
malnutrition risk screening tools 
 PYMS STAMP STRONGKIDS 
MUAC 
N=4071 N=3891 N=4011 
low medium high low medium high low medium high 
Mean  
(SD) 
0.52 
(1.17) 
0.24 
(1.18) 
-0.27 
(1.13) 
0.44 
(1.15) 
0.31 
(1.11) 
-0.21 
(1.33) 
0.67 
(1.13) 
0.17 
(1.29) 
-0.81 
(1.16) 
≥ -1SDS 197 75 82 119 149 69 156 173 19 
<-1 to ≥-2 
SDS 
13 12 16 10 18 13 5 27 9 
< -2 SDS 4 0 8 1 1 9 0 7 5 
TSFT 
N=3822 N=3612 N=3652 
low medium high low medium high low medium high 
Mean 
(SD) 
1.13 
(1.22) 
0.85 
(1.12) 
0.42 
(1.33) 
0.96 
(1.23) 
0.88 
(1.15) 
0.75 
(1.50) 
1.09 
(1.23) 
0.87 
(1.30) 
0.34 
(1.32) 
≥ -1SDS 192 81 84 117 150 70 140 178 23 
< 1 to ≥2 
SDS 
8 2 10 7 4 8 7 9 3 
< -2 SDS 0 1 4 1 2 2 0 4 1 
 
1
 All children with completion of the tool and MUAC (e.g. PYMS and MUAC) 
2 All children with completion of the tool and TSFT (e.g. PYMS and TSFT). 
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PYMS: Pediatric Yorkhill Malnutrition Score; STAMP: Screening Tool for the Assessment of 
Malnutrition in Pediatrics; STRONGKIDS: Screening Tool for Risk Of Impaired Nutritional Status and 
Growth; SD: standard deviation; MUAC: mid upper arm circumference; TSFT: triceps skin fold 
thickness 
 The American Journal of Clinical Nutrition AJCN/2015/110700 Version 4
 36
Figure 1: Malnutrition risk classification based on the 3 screening tools expressed as percentages of the 
total number of assessed children for each tool. 
 
 
Figure 2: Prevalence of malnutrition risk in different countries using the different screening tools. 
 The American Journal of Clinical Nutrition AJCN/2015/110700 Version 4
  
 
0%
10%
20%
30%
40%
50%
60%
70%
80%
low risk medium risk high risk
PYMS
STAMP
STRONGkids
 The American Journal of Clinical Nutrition AJCN/2015/110700 Version 4
0%
10%
20%
30%
40%
50%
60%
70%
80%
Croatia 
(n=217) 
Denmark 
(n=81)
England 
(n=158)
France 
(n=301)
Germany 
(n=161)
Greece 
(n=215)
Israel    
(n=124)
Italy     
(n=219)
Netherlands 
(n=131)
Poland 
(n=200)
Romania 
(n=218)
Scotland 
(n=211)
STRONGkids
low medium high
 
0%
10%
20%
30%
40%
50%
60%
70%
80%
Croatia 
(n=164) 
Denmark 
(n=71)
England 
(n=100)
France 
(n=200)
Germany 
(n=153)
Greece 
(n=140)
Israel    
(n=67)
Italy     
(n=169)
Netherlands 
(n=143)
Poland 
(n=143)
Romania 
(n=175)
Scotland 
(n=144)
PYMS
low medium high
0%
10%
20%
30%
40%
50%
60%
70%
80%
Croatia 
(n=146) 
Denmark 
(n=67)
England 
(n=91)
France 
(n=178)
Germany 
(n=126)
Greece 
(n=109)
Israel     
(n=58)
Italy    
(n=139)
Netherlands 
(n=132)
Poland 
(n=151)
Romania 
(n=151)
Scotland 
(n=123)
STAMP
low medium high
 
The Am
erican Journal of Clinical Nutrition AJCN/2015/110700 Version 4
